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Prevention of  stroke has been a key target for health 
care interventions in developed countries for decades, with 
recent WHO statistics demonstrating a 42% decrease in 
stroke incidence since 1970 [1]. This trend is not observed 
uniformly worldwide, with the same review demonstrating 
a 100% increase in stroke incidence in developing countries 
over a similar time period. Economic changes in these 
countries are anticipated to amplify this problem, with 
key risk factors for stroke also increasing in prevalence [2, 
3]. Furthermore, more effective treatment of  childhood 
diseases will likely increase the proportion of  elderly 
people in these countries, further increasing the burden of  
chronic disease. A large hospital based study in Tanzania 
estimated the incidence of  stroke to be between 108-316 
per 100,000 [4] with significant differences between rural 
and urban populations. However considerable variation in 
this estimate has been observed in several smaller studies 
[5, 6]. Information concerning the community incidence 
of  stroke is scarce with only one large study demonstrating 
a significantly lower incidence of  stroke than hospital 
based studies [7]. Reliable information on stroke in sub-
Saharan Africa (SSA) is therefore poor and it is difficult 
to accurately estimate stroke incidence in its population. 
Nevertheless, the aforementioned studies demonstrate a 
steady, yet substantial increase in the burden of  stroke, 
hence necessitating further research and implementation 
of  appropriate prevention strategies. 
The rising incidence of  stroke and stroke associated 
morbidity is especially problematic in SSA. Financial 
constraints and delayed presentation [8] contribute to 
a high case fatality rate. Two studies in Tanzania and 
Gambia recently demonstrated 1-month fatality rates of  
24% and 27% respectively [9,10]. Comparison with fatality 
rates of  <20% in developed countries [2] demonstrates 
a significant area of  healthcare deficit with important 
implications in the context of  a rising stroke incidence. 
A large study conducted in Mozambique suggested that 
in-hospital complications had the strongest influence on 
case fatality [11]. Greater prioritisation to acute stroke 
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management therefore could have a large impact on case 
fatality in these countries. Other studies demonstrate 
significant variation in mortality rates throughout SSA, 
with some studies revealing 28-day mortality rates of  
>40% [12]. This emphasises the need for more rigorous 
studies detailing key factors affecting mortality throughout 
SSA populations. In addition to acute stroke mortality, 
the burden of  stroke morbidity is especially high. One 
study recently estimated a seven times greater number of  
disability-adjusted life years lost in developing countries in 
comparison with their developed counterparts [13]. Long 
term care of  patients following a stroke is healthcare 
intensive and often unavailable in sub-Saharan countries. 


























Table 1. Relative contribution of  cardiovascular risk 
factors to stroke
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Such substantial morbidity rates, combined with an 
increasing incidence of  stroke in these populations, will 
have profound economic effects at a national level.  
Preventative strategies aimed at reducing stroke 
incidence and mortality need first to identify key risk 
factors for stroke in sub-Saharan populations. Studies 
specifically in this demographic however, with the 
exception of  hypertension, are rare. 
Multiple studies have identified hypertension as the 
leading risk factor for stroke in SSAs [14] with a Nigerian 
study demonstrating >80% prevalence of  hypertension 
in stroke patients [15]. Sub-Saharan populations appear 
to be more at-risk of  developing hypertension and 
subsequent stroke. Current literature demonstrates 
higher mean systolic and diastolic blood pressures (BP) 
in people of  African descent in comparison with their 
Caucasian counterparts [16]. Furthermore a recently 
published multi-centred study demonstrated a 2 to 5 
fold increase in stroke incidence in a population of  black 
Americans [17]. This difference could be accounted for 
by a combination of  factors, including hypertension. A 
large study conducted in South Africa suggested that 
up to 45% of  strokes in SSAs could be prevented by 
simple blood pressure control measures [18]. Inadequate 
funding and lack of  infrastructure however often impair 
diagnosis and screening of  hypertension. With an 
increase in stroke incidence, detection and management 
of  hypertension must become a greater priority. The 
contribution of  eclampsia to stroke incidence should also 
not be underestimated. Of  those patients who progress 
to eclampsia, approximately 4.9% will develop a stroke 
[19]. This represents a small but not insignificant portion 
of  stroke burden in this population. Better access to 
maternal health care services could play an important role 
in reducing pregnancy related stroke. 
Additional cardiovascular risk factors for stroke in 
this population have a less obvious contribution to stroke 
aetiology. Several studies have investigated the incidence of  
these risk factors in patients from sub-Saharan countries 
and these are documented in table 1. 
These risk factors appear to have variable effects 
on stroke risk in accordance with racial group. The 
large population-based NOMASS study [24] recently 
demonstrated an increased risk of  stroke in black 
populations and made comparisons of  the relative 
contributions of  risk factors by ethnicity. Hypertension 
and diabetes had a substantially higher aetiological fraction 
in black populations, whereas atrial fibrillation (AF) and 
the presence of  coronary artery disease were stronger 
predictors of  stroke in white populations. These results 
are summarised in Table 2. 
Despite non-significance, this study demonstrates 
the substantial contribution of  hypertension to stroke in 
Black populations and emphasises the potential benefit 
of  BP control. Furthermore the increased etiological 
fraction for stroke in black diabetic patients highlights 
the importance of  good glycaemic control in stroke 
prevention. Interestingly, the risk of  stroke resulting 
from AF appears to be much reduced in comparison to 
the white study population. This could have important 
implications when considering the risks surrounding anti-
coagulant treatment in SSA. 
WHO data indicates a high estimated prevalence of  
4.8% of  HIV in SSA populations [25] with considerable 
variation throughout different regions. Research has 
investigated the link between HIV and risk of  stroke 
with substantial evidence suggesting an increased risk of  
ischaemic stroke in HIV-positive patients [26,27,28,29]. 
In particular, HIV appears to disproportionately increase 
ischaemic stroke risk in young patients, with one study 
demonstrating an Odds Ratio of  >4 in patients aged 
18-30 years [26]. This finding is further supported by a 
Malawian study which demonstrated that HIV-positive 
stroke patients were on average 24 years younger than 
their HIV-negative counterparts [27]. In the same 
study HIV-positive patients had a lower incidence of  
common cardiovascular risk factors, further suggesting 
the causal link between HIV and ischemic stroke. The 
 Risk Factors White Black
Odds Ratio Etiological Fraction(%) Odds Ratio Etiological Fraction(%)
Hypertension 1.8 25 2.0 37
Diabetes 1.0 0 1.8 14
Atrial Fibrillation 4.4  20* 1.7 3*
Coronary Artery 
Disease 1.3 16 1.1 6
*Significant difference in causative fraction in comparison between white and black populations (p<0.04)
Table 2. Contribution of  risk factors for stroke: a comparison between ethnicities [24]
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reasons for this relationship are uncertain but the role of  
opportunistic infection, hypercoaguability and accelerated 
artherosclerosis are hypothesised [28]. The affect of  
HIV on risk of  haemorrhagic stroke is less certain. One 
study suggested an odds ratio of  >7 for intra-cerebral 
haemorrhage in patients with AIDS defining symptoms 
compared with a HIV-negative cohort, with no significant 
increase for asymptomatic HIV-positive patients [29]. This 
compliments the results of  an aforementioned study [26] 
suggesting that risk of  both haemorrhagic and ischaemic 
stroke is strongly predicted by disease severity and viral 
loads. 
More effective and comprehensive treatment of  
childhood and infectious diseases in SSA will lead to an 
older population, with higher chronic disease burden. 
Increasing prevalence of  cardiovascular risk factors 
will further increase the mortality and morbidity caused 
by stroke in these countries. Risk factors for stroke are 
well known but an uncertainty surrounding each factor’s 
contribution to stroke risk in this population must first be 
determined. Further research specifically in sub-Saharan 
countries is required to help guide potentially simple, yet 
effective interventions to curb the trend of  a potential 
stroke epidemic. 
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ANSWErS TO PHOTO qUIz FrOM AUgUST ISSUE
What name is given to this facial physical sign?1. 
 Risus sardonicus (trismus).
What is the underlying cause?2. 
 Tetanus caused by Clostridium tetani infection of  a wound
What parts of  the body are most likely to be the infected foci?3. 
 Hands, legs and feet: in neonates the cut umbilicus.
Describe the cardiovascular complications.4. 
 These arise from the disturbance of  the autonomic nervous system causing tachycardia, 
 hypo / hypertension, peripheral vasoconstriction and shock.A sudden tachycardia plus
  hypertension is called an “autonomic storm” and is followed by bradycardia and  
 hypotension. A variety of  cardiac dysrhythmias (including ventricular tachycardia) may occur.
What is the risk of  sucking out (aspirating) secretions from the trachea?5. 
 Stimulation of  the trachea may increase the vagal tone leading to severe bradycardia and even   
 cardiac arrest. This procedure must be carried out very gently.
With what apparently minor symptom might a neonatal case of  this condition present?6. 
 Difficulty with suckling.
We are grateful to Dr. David Webster for providing this photograph of  his experience in Amudat Hospital, Uganda when he was there as Medical 
Superintendant in the 1960’s.
